13734-38-8

Basic information

• Product Name: Boc-Ser(tBu)-OH
• Synonyms: BOC-SER(BUT)-OH;BOC-SER(BU)-OH;BOC-SERINE(TBU)-OH;BOC-SER(TBU)-OH;BOC-SER-OTBU;BOC-O-TERT-BUTYL-L-SERINE;BOC-O-T-BUTYL-L-SERINE;BOC-L-SER(TBU)-OH
• CAS NO: 13734-38-8
• Molecular Formula: C₁₂H₂₃NO₅
• Molecular Weight: 261.31
• EINECS: 1533716-785-6
• Product Categories: Amino Acids;Boc-Amino Acids and Derivative;Boc-Amino acid series;peptides
• Mol File: 13734-38-8.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 383.1oC at 760 mmHg
• Flash Point: 185.5oC
• Appearance: /
• Density: 1.087g/cm3
• Vapor Pressure: 6.22E-07mmHg at 25°C
• Refractive Index: 1.463
• Storage Temp.: Store at 0°C
• PKA: 3.55±0.10(Predicted)
• CAS DataBase Reference: Boc-Ser(tBu)-OH(CAS DataBase Reference)
• NIST Chemistry Reference: Boc-Ser(tBu)-OH(13734-38-8)
• EPA Substance Registry System: Boc-Ser(tBu)-OH(13734-38-8)

Safety Data

• Hazardous Substances Data: 13734-38-8(Hazardous Substances Data)

Usage

Chemical Properties

Light yellowish oil or white crystals

InChI:InChI=1/C12H23NO5/c1-11(2,3)17-7-8(9(14)15)13-10(16)18-12(4,5)6/h8H,7H2,1-6H3,(H,13,16)(H,14,15)/t8-/m0/s1

Upstream product

• 18595-34-1 tert-butyl fluoroformate 
• 18822-58-7 (S)-O-tert-butylserine 
• 18942-50-2 Boc-Ser(OBu^t)-OH*dicyclohexylamine 

Downstream Products

• 110575-58-1 Nα-(t-butoxycarbonyl)-O-(t-butyl)seryl-O-(benzyl)glutamyl-O-(benzyl)glutamyl methylamide 
• 110575-60-5 Nα-(t-butoxycarbonyl)-O-(t-butyl)seryl-O-(t-butyl)seryl-O-(benzyl)glutamyl-O-(benzyl)glutamyl methylamide 
• 82594-45-4 Nα-(t-butoxycarbonyl)-O-(t-butyl)seryl-O-(t-butyl)seryl-O-(t-butyl)seryl-O-(benzyl)glutamyl-O-(benzyl)glutamyl methylamide 
• 330624-99-2 H-Ala-Tyr-Asp-Ala-Lys(Ser)-Ala-NH-CH₂-CH(OCH₃)2 
• 930285-06-6 Boc-L-Ser(tBu)-L,D-PheSer-OMe 
• 936707-05-0 C₂₄H₄₇N₅O₁₀ 
• 208777-14-4 [(S)-5-({(S)-1-[(S)-2-((R)-2-Acetylamino-3-mercapto-propionylamino)-3-tert-butoxy-propionyl]-pyrrolidine-2-carbonyl}-amino)-5-((S)-5-benzyloxycarbonylamino-1-methylcarbamoyl-pentylcarbamoyl)-pentyl]-carbamic acid benzyl ester 

Relevant articles and documents

TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS

This invention relates to compounds with the formula (I) given below or one of their pharmaceutically acceptable salts, as a medicine; Formula (I) of pharmaceutical compositions comprising one or more compounds with Formula (I) as active constituent, use